SUBSCRIBE
SUBSCRIBE
News   Policy

Cornerstone Therapeutics Inc. Gets U.S. FDA Warning

November 23, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators warned Cornerstone Therapeutics that the company has distributed drugs without approved applications, a letter released on Friday said.
Regulatory
Food and Drug Administration (FDA) Chiesi, USA
MORE ON THIS TOPIC
Organizing Solutions and organizer concept as a Management leadership taking charge as a leader sorting out diverse ropes into an organized patterns as a business concept for strategy and control.
FDA
JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year
January 19, 2026
 · 
6 min read
 · 
Heather McKenzie
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Former Emergent CEO Hit With Insider Trading Lawsuit
January 16, 2026
 · 
2 min read
 · 
Tristan Manalac
Drug pricing
Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’
January 15, 2026
 · 
2 min read
 · 
Annalee Armstrong
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
FDA
FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report
January 15, 2026
 · 
2 min read
 · 
Tristan Manalac